Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Impulsivity, Active Suicidal Ideation, Depression

In brief

This study is dedicated to achieving a better understanding of how the brain processes information. Specifically, the investigators are studying cognitive function, thought process, and impulsivity in people with and without suicidal thoughts. You are being asked to participate in a research study to learn how the use of a medication, risperidone, improves your symptoms of depression. Specifically the investigators are studying the effectiveness of reducing the thought of suicide and other symptoms of severe depression. Risperidone is approved by FDA for the treatment of schizophrenia and bipolar mania, and clinical practice suggests that it might benefit patients with major depressive disorder. During clinical trials with 2607 patients, risperidone was proved to be safe. This is a pilot study to test a new indication of risperidone for treatment of severe depression. The study medication will be given in addition to usual psychiatric care.

Key facts

Study ID
NCT01770600
Run by
University of Alabama at Birmingham
People needed
0
Starts
2010-04-01
Last updated by the study team
2015-05-28

Who can join

Age: 19 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.